
Immuron Limited IMRN
€ 0.65
-6.67%
Geschäftsbericht 2022
hinzugefügt 09.09.2022
Immuron Limited ROE 2011-2026 | IMRN
ROE Jährlich Immuron Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.31 | -32.38 | -51.86 | -63.02 | -35.68 | -103.49 | - | - | - | - | - | - |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -12.31 | -103.49 | -49.79 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.85 | 3.22 % | $ 9.26 B | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 326.56 | -2.05 % | $ 42.8 B | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-45.18 | $ 7.76 | 4.51 % | $ 76.7 M | ||
|
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
103.22 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.44 | $ 21.48 | -0.92 % | $ 1 B | ||
|
Burford Capital Limited
BUR
|
10.1 | $ 4.7 | -0.74 % | $ 756 M | ||
|
CymaBay Therapeutics
CBAY
|
-36.05 | - | - | $ 3.45 B | ||
|
Cabaletta Bio
CABA
|
-149.8 | $ 3.45 | 1.32 % | $ 347 M | ||
|
BioNTech SE
BNTX
|
1.11 | $ 99.42 | -0.05 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.1 | -4.32 % | $ 5.1 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
549.72 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-16.39 | $ 1.41 | -9.12 % | $ 363 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
248.9 | $ 4.16 | -1.89 % | $ 445 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 24.22 | -1.46 % | $ 3.08 B | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
45.18 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.48 | -0.67 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
6.58 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
445.47 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-67.58 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
204.15 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
-49.08 | $ 33.53 | -1.0 % | $ 2.23 B | ||
|
bluebird bio
BLUE
|
-108.93 | - | - | $ 546 M | ||
|
CNS Pharmaceuticals
CNSP
|
-350.48 | $ 2.66 | -3.34 % | $ 1.18 M | ||
|
AstraZeneca PLC
AZN
|
20.44 | - | - | $ 96.9 B |